Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
NEOG
HOLDNeogen Corporation · Healthcare · United States · $2.0B · Avg Vol: $17M/d
COMPANY DESCRIPTION
Neogen Corporation develops and markets products dedicated to food and animal safety, including diagnostic test kits and genomic services. The company's diverse portfolio addresses critical needs in preventing food contamination and improving animal health and performance. Its global reach, strong R&D, and regulatory compliance position it as a leader in providing solutions for a safer food supply chain.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 527.2M | 822.4M | 924.2M | 894.7M | 19.3% | 870.6M | 857.4M | 849.0M | -2.6% |
| EPS | 0.22 | -0.11 | -0.04 | -5.03 | — | -2.73 | — | — | — |
| Shares | 217.7M | 216.2M | 216.6M | 217.0M | -0.3% | 217.7M | — | — | — |
| Debt | — | 885.4M | 890.8M | 894.1M | 0.5% | 795.1M | — | — | — |
| Equity | 887.4M | 3.1B | 3.1B | 2.1B | 32.7% | — | — | — | — |
| Op CF | 68.0M | 41.0M | 35.3M | 58.2M | -5.0% | 69.4M | — | — | — |
| Inv CF | -97.2M | 201.0M | -29.3M | -99.2M | — | — | — | — | — |
| Fin CF | 6.8M | -118.1M | 1.9M | -1.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NEOG are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NEOG | Neogen Corporation(you) | $2.0B | 37 | HOLD |
| ESTA | Establishment Labs Holdings Inc. | $2.7B | 36 | HOLD |
| BFLY | Butterfly Network, Inc. | $1.7B | 34 | SELL |
| TMDX | TransMedics Group, Inc. | $2.5B | 34 | SELL |
| IRTC | iRhythm Holdings, Inc. | $3.6B | 30 | SELL |
| ATEC | Alphatec Holdings, Inc. | $1.3B | 27 | SELL |
| QDEL | QuidelOrtho Corporation | $1.1B | 47 | HOLD |
| TNDM | Tandem Diabetes Care, Inc. | $1.2B | 25 | SELL |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | 26 | SELL |
| AXGN | Axogen, Inc. | $2.1B | 62 | HOLD |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.7%